USANA Health Sciences Inc
NYSE:USNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
USANA Health Sciences Inc
NYSE:USNA
|
US |
|
Assa Abloy AB
STO:ASSA B
|
SE |
|
Credicorp Ltd
NYSE:BAP
|
PE |
|
C
|
Cybozu Inc
TSE:4776
|
JP |
|
G
|
Growthpoint Properties Ltd
JSE:GRT
|
ZA |
|
State Street Corp
NYSE:STT
|
US |
|
O
|
Ondo InsurTech PLC
LSE:ONDO
|
UK |
|
Nexgen Energy Ltd
TSX:NXE
|
CA |
|
FILA Fabbrica Italiana Lapis ed Affini SpA
MIL:FILA
|
IT |
|
Guangdong Songfa Ceramics Co Ltd
SSE:603268
|
CN |
|
Eltel AB
STO:ELTEL
|
SE |
Wall St Price Targets
USNA Price Targets Summary
USANA Health Sciences Inc
According to Wall Street analysts, the average 1-year price target for USNA is 39.78 USD with a low forecast of 39.39 USD and a high forecast of 40.95 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is USNA's stock price target?
Price Target
39.78
USD
According to Wall Street analysts, the average 1-year price target for USNA is 39.78 USD with a low forecast of 39.39 USD and a high forecast of 40.95 USD.
What is the Revenue forecast for USANA Health Sciences Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is 5%.
What is the Operating Income forecast for USANA Health Sciences Inc?
Projected CAGR
22%
Over the last 14 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 2 years is 22%.
What is the Net Income forecast for USANA Health Sciences Inc?
Projected CAGR
120%
Over the last 14 years, the compound annual growth rate for Net Income has been -6%. The projected CAGR for the next 2 years is 120%.
